Skip to content

Clinical trials

Observational Carcinoma, Renal Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Observational Country / region: United States Clear all

85 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20032
20041
20052
20062
20071
20083
20093
20104
20113
20124
20132
20143
20153
20161
20174
20182
20194
20208
20219
202210
20233
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Recruiting13
Terminated9
Active, not recruiting8
Withdrawn5
Unknown status3
Not yet recruiting2
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer7
National Cancer Institute (NCI)5
Mayo Clinic4
Duke University3
Wake Forest University Health Sciences3
A2 Biotherapeutics Inc.2
Children's Oncology Group2
City of Hope Medical Center2
M.D. Anderson Cancer Center2
Stanford University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell85
Kidney Neoplasms21
Melanoma18
Urinary Bladder Neoplasms14
Carcinoma, Non-Small-Cell Lung13
Colorectal Neoplasms12
Carcinoma, Hepatocellular11
Pancreatic Neoplasms10
Prostatic Neoplasms10
Uterine Cervical Neoplasms10

Trials

Showing 1 to 25 of 85. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.